|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 47/02 | |
| A61K 47/12 | |||
| A61K 47/18 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2116265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09010433.2 |
| Europos patento paraiškos padavimo data | 2001-10-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-11-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 240107 P | 2000-10-12 | US | |
| 293834 P | 2001-05-24 | US |
| (72) |
Liu, Jun, US
Shire, Steven J., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
Novartis AG, Lichtstrasse 35, 4056 Basel, CH |
| (54) | Reduced-viscosity concentrated protein formulations |
| Reduced-viscosity concentrated protein formulations |